Effects of Clopidogrel with Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Bare-Metal Stent

被引：0
|
作者：
Hsieh, Chi-Feng [1 ]
Lu, Pei-Yu [1 ]
Huang, Weng-Foung [1 ]
机构：
[1] Natl Yang Ming Univ, Coll Med, Inst Hlth & Welf Policy, Taipei 112, Taiwan
来源：
DRUG SAFETY | 2012年 / 35卷 / 10期
关键词：
ADVERSE OUTCOMES; CONCOMITANT USE; RISK;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：917 / 918
页数：2
相关论文
共 50 条
  • [21] Impact of Pioglitazone on Cardiovascular Events in Patients with Type-2 Diabetes Mellitus after Drug-eluting Stent Implantation
    Yokoi, Hiroyoshi
    Nakamura, Masato
    Muramatsu, Toshiya
    Okada, Hisayuki
    Ochiai, Masahiko
    Suwa, Satoru
    Matsuyama, Yutaka
    Nanto, Shinsuke
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B65 - B65
  • [22] Impact of Pioglitazone on Cardiovascular Events in Patients With Type-2 Diabetes Mellitus after Drug-Eluting Stent Implantation
    Yokoi, Hiroyoshi
    Nakamura, Masato
    Muramatsu, Toshiya
    Okada, Hisayuki
    Ochiai, Masahiko
    Suwa, Satoru
    Matsuyama, Yutaka
    Nanto, Shinsuke
    DIABETES, 2013, 62 : A311 - A311
  • [23] A comparison of paclitaxel vs. bare metal stent thrombosis in patients with STEMI using clopidogrel with proton pump inhibitors after postfibrinolysis angioplasty. A GRACIA-3 substudy
    Sanchez Fernandez, P. L.
    Gimeno, F.
    Ancillo, P.
    Sanz, J. J.
    Alonso Briales, J. H.
    Bosa, F.
    Santos, I.
    Sanchis, J.
    San Roman, J. A.
    Fernandez Aviles, F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 221 - 221
  • [24] Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study
    Davis, Timothy M. E.
    Drinkwater, Jocelyn
    Davis, Wendy A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (08): : 2985 - 2993
  • [25] Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study
    Kreutz, Rolf P.
    Stanek, Eric J.
    Aubert, Ronald
    Yao, Jianying
    Breall, Jeffrey A.
    Desta, Zeruesenay
    Skaar, Todd C.
    Teagarden, J. Russell
    Frueh, Felix W.
    Epstein, Robert S.
    Flockhart, David A.
    PHARMACOTHERAPY, 2010, 30 (08): : 787 - 796
  • [26] Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation
    Tentzeris, Ioannis
    Jarai, Rudolf
    Farhan, Serdar
    Brozovic, Ivan
    Smetana, Peter
    Geppert, Alexander
    Wojta, Johann
    Siller-Matula, Jolanta
    Huber, Kurt
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1211 - 1218
  • [27] Proton pump inhibitors increase the risk of major adverse cardiovascular events in post-PCI patients who are on clopidogrel
    Banerjee, S.
    Varghese, C.
    Weideman, R.
    Weideman, M.
    Little, B. B.
    EUROPEAN HEART JOURNAL, 2009, 30 : 92 - 93
  • [28] Attitude of Prescribing Proton Pump Inhibitors in Patients Using Clopidogrel for Secondary Prevention of Cardiovascular Events Utilizing Survey Study
    Niyomnaitham, Suvimol
    Kimmel, Stephen E.
    Bilker, Warren B.
    Holmes, John H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 294 - 294
  • [29] Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus
    Maeng, Michael
    Jensen, Lisette O.
    Kaltoft, Anne
    Hansen, Hans H. T.
    Bottcher, Morten
    Lassen, Jens F.
    Thayssen, Per
    Krusell, Lars R.
    Rasmussen, Klaus
    Pedersen, Lars
    Sorensen, Henrik T.
    Johnsen, Soren P.
    Thuesen, Leif
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (02): : 165 - 172
  • [30] Adverse events in patients with cardiovascular disease taking proton pump inhibitors
    Lanas-Gimeno, Aitor
    Lanas, Angel
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (11) : 1381 - 1391
12345